Table 1.
Characteristics of the patients before (pre-RGT group) and after (RGT current study group) the implementation of M. genitalium diagnostics with macrolide-resistance detection.
| Pre-RGT Group [19], n (%) | RGT, n (%) | |||
|---|---|---|---|---|
| Male (n = 18) | Female (n = 3) | Male (n = 14) | Female (n = 3) | |
| Median age (range) | 32 (22–49) | 28 (23–33) | 29 (18–47) | 29 (23–34) |
| Presentation | ||||
| Symptomatic | 15 (83.3) | 1 (33.3) | 12 (85.7) | 2 (66.7) |
| Asymptomatic contact | 3 (16.7) | 2 (66.7) | 2 (14.3) | 1 (33.3) |
| Specimen | ||||
| First-void urine | 14 (77.8) | 0 (0) | 7 (50) | 0 (0) |
| Urogenital swab | 4 (22.2) | 3 (100) | 5 (35.7) | 3 (100) |
| Extra-genital swab | 0 (0) | 0 (0) | 2 * (14.3) | 0 (0) |
* Rectal M. genitalium infections.